HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robin Whittaker Selected Research

Neoplasms (Cancer)

6/2009Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530.
11/2007Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robin Whittaker Research Topics

Disease

2Neoplasms (Cancer)
06/2009 - 11/2007
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2009
1Neoplasm Metastasis (Metastasis)
06/2009

Drug/Important Bio-Agent (IBA)

1saracatinibIBA
06/2009
1PaxillinIBA
06/2009
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2007
11-aminobenzotriazoleIBA
11/2007